Get started

Stockstobuy

Sudarshan Chemicals looking to rotate and shineSudarshan Chemicals Industries Ltd is a global supplier of high-end pigments with a diverse range of products ranging from organic, inorganic and effect pigments to performance colorants, pearlescent pigments and speciality chemicals. Products of the company mainly use in Art and craft, paper, agriculture and textile. Sudarshan Chemicals Industries Ltd CMP is 487.10. Negative aspects of the company are high valuation ( P.E. = 75.3), declining annual net profits, MFs are decreasing stake. Positive aspects of the company are low debt, improving cash from operations annuals, FIIs are increasing stake, zero promoter pledge. Entry can be taken after closing above 498. Targets in the stock will be 520 and 542. Long term target in the stock will be 579. Stop loss in the stock should be maintained at closing below 458.
NSE:SUDARSCHEMLong
by Happy_Candles_Investment
New LogoAs you all have probably seen, we have changed our logo and name! Shortly, we will go online with our website on which were are going to provide you with free daily market updates - more than one per day. But for the time being, let us look at the 3M chart where we can see an increasingly strong bullish impulse. It is important that the pressure is kept high until we confidently cross the resistance at $117.80. There, we should see a small setback, before the bulls take over again. It is important that the course remains above $92.38.
NYSE:MMMLong
by MarketIntel
Siemens trying to break the mid channel resistanceSiemens Ltd. is a technology company focused on industry, infrastructure, digital transformation, transport as well as transmission and generation of electrical power. Siemens has signed a 3 billion euro ($3.25 billion) contract to supply and service freight trains in India. Siemens CMP is 3694.90. Negative aspects of the company are high valuation (P.E. = 69.7), declining cash from operations annual, MFs are decreasing stake. Positive aspects of the company are improving annual net profits, no debt, FIIs are increasing stake and zero promoter pledge. Entry after closing above 3713. Target of the call will be 3779 and 3881. Long term targets in the stock will be 3953. Stop loss in the stock should be maintained at closing below 3315.
NSE:SIEMENSLong
by Happy_Candles_Investment
Eid Parry trying to parry out of tough timesE.I.D. Parry (India) Ltd. is engaged in the business of Sugar and Nutraceuticals. The company is amongst the leading sugar manufacturers in India, E.I.D. Parry’s 9 sugar plants are spread across South India. It is also a part of the INR 369 Billion Murugappa Group, one of India’s leading business conglomerate. E.I.D. Parry (India) CMP is 480.70. Negative aspects of the company are declining annual net profits, promoter decreasing stake, FIIs are decreasing stake and MFs are decreasing stake. Positive aspects of the company are no debt and improving cash from operations annual. Entry after closing above 488. Target of the call will be 507 and 546. Long term targets in the stock will be 584 and 629. Stop loss in the stock should be maintained at closing below 435.
NSE:EIDPARRYLong
by Happy_Candles_Investment
Why Bayer Stock is a Great Long-Term Investment OpportunityBayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. The company is headquartered in Leverkusen, Germany, and employs over 100,000 people worldwide. Bayer's core business areas are human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, and biotechnology products. Bayer stock is a great long-term investment opportunity for several reasons. The first one is that its stock has created a strong weekly demand level located at around 49 euros per share. This should be enough reason to buy Bayer AG stock shares. Secondly, the company has a strong history of financial stability and profitability. In addition, Bayer has a diversified product portfolio with exposure to many different industries. Bayer is committed to innovation and has a strong R&D pipeline. Bayer AG is a publicly traded company with shares that trade on the Frankfurt Stock Exchange, and the company has a market capitalization of over €51 billion. The company's stock has not performed well in recent years, losing more than 70% of its value since up more than 50% since 2016. It's now a great opportunity to buy shares of Bayer AG stock. There is a lot of profit potential with room to reach €88 per share and higher.
XETR:BAYNLong
by AlfonsoMoreno
ATUL Ltd.can accommodate growth. Atul Ltd. is an integrated chemical company serving about 4000 customers belonging to 30 industries across the world. The company product portfolio utility includes area of aromatics, crop protection, polymers, pharma ingredients and many more. Atul CMP is 7014.15. Negative aspects of the company are high valuation (P.E. = 45.7), declining annual net profits, FIIs are decreasing stake and MFs are decreasing stake. Positive aspects of the company are no debt and improving cash from operations annual. Entry after closing above 7056. Target of the call will be 7373 and 7884. Long term targets in the stock will be 8402 and 8921. Stop loss in the stock should be maintained at closing below 5594.
NSE:ATULLong
by Happy_Candles_Investment
LIC of India trying to make a comeback after consolidation.Life Insurance Corporation of India is the largest multinational insurance corporation and an institutional investor with an asset under management of more than 45 trillion INR. The company offers insurance plans, pension plans, unit linked plans, withdrawn plans and health plans with many other group schemes. Life Insurance Corporation CMP is 635.75. Negative aspects of the company are declining cash from operations and MFs are decreasing stake. Positive aspects of the company are improving annual net profits, no debt and zero promoter pledge. Entry after closing above 643. Target of the call will be 653 and 666. Long term targets in the stock will be 681 and 704. Stop loss in the stock should be maintained at closing below 595.
NSE:LICILong
by Happy_Candles_Investment
Unveiling the Potential of Pfizer Pharmaceutical Stock in 2023Are you searching for a lucrative investment opportunity that promises great returns in 2023? Look no further as we unveil the hidden potential of Pfizer Pharmaceutical stock. In this blog post, we will delve into the compelling reasons why investing in Pfizer is not only a smart move but also an incredibly exciting. From groundbreaking innovations to robust financial performance, join us as we explore why Pfizer is poised to be a game-changer in the pharmaceutical industry and how you can reap substantial rewards by including it in your investment portfolio. Don’t miss out on this exclusive insight into what could be your most profitable venture yet! Monthly price action is supporting a strong bullish correction in the following months. Pfizer is one of the world’s leading pharmaceutical companies and was at the forefront of developing a vaccine for Covid-19 in 2020. The stock price reflected the impact of the vaccine until December 2021, when the stock plunged, losing almost 50% of its value. It’s then when a longer-term demand imbalance takes control and helps us make a high-probability decision to buy and hold shares of Pfizer PFE stock.
NYSE:PFE
by AlfonsoMoreno
Abbott Laboratories in a bull flag.Abbott Labratories - 30d expiry - We look to Buy a break of 109.51 (stop at 106.31) The primary trend remains bullish. This stock has seen good sales growth. Expect trading to remain mixed and volatile. 109.34 has been pivotal. Posted a bullish Flag formation. A break of 109.34 is needed to confirm the outlook. The bias is to break to the upside. Our profit targets will be 117.51 and 119.51 Resistance: 108.50 / 109.34 / 112.95 Support: 106.80 / 105.96 / 104.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
NYSE:ABTLong
by VantageMarkets